Recerca > Nutrició, Metabolisme i Estrès Cel·lular

Fisiopatologia metabòlica

Nombre de publicacions
377
Cercador de publicacions
  • Torres, P; Rico-Rios, S; Ceron-Codorniu, M; Santacreu-Vilaseca, M; Seoane-Miraz, D; Jad, Y; Ayala, V; Mariño, G; Beltran, M; Miralles, MP; Andrés-Benito, P; Fernandez-Irigoyen, J; Santamaria, E; López-Otín, C; Soler, RM; Povedano, M; Ferrer, I; Pamplona, R; Wood, MJA; Varela, MA; Portero-Otin, M

    TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition

    ACTA NEUROPATHOLOGICA 148 45-45. .

    [doi:10.1007/s00401-024-02780-4]

  • Ceron-Codorniu, M; Torres, P; Fernández-Bernal, A; Rico-Rios, S; Serrano, JCE; Miralles, MP; Beltran, M; Garcera, A; Soler, RM; Pamplona, R; Portero-Otín, M

    TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells

    Redox Biology 75 103301-103301. .

    [doi:10.1016/j.redox.2024.103301]

  • Rosell-Díaz M; Petit-Gay A; Molas-Prat C; Gallardo-Nuell L; Ramió-Torrentà L; Garre-Olmo J; Pérez-Brocal V; Moya A; Jové M; Pamplona R; Puig J; Ramos R; Bäckhed F; Mayneris-Perxachs J; Fernández-Real JM

    Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.

    Metabolism: clinical and experimental 157 155941-155941. .

    [doi:10.1016/j.metabol.2024.155941]

  • Dakterzada, F; Jové, M; Cantero, JL; Mota-Martorell, N; Pamplona, R; Piñoll-Ripoll, G

    The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease

    ALZHEIMERS & DEMENTIA 20 3322-3333. .

    [doi:10.1002/alz.13792]

  • Oros Ruiz M; Perejón López D; Serna Arnaiz C; Siscart Viladegut J; Àngel Baldó J; Sol J

    Maternal and foetal complications of pregestational and gestational diabetes: a descriptive, retrospective cohort study.

    SCIENTIFIC REPORTS 14 9017-9017. .

    [doi:10.1038/s41598-024-59465-x]

  • Salina-Roca, B; Sánchez, E; Bermúdez-López, M; Valdivielso, JM; Farràs-Sallés, C; Pamplona, R; Torres, G; Mauricio, D; Castro, E; Fernández, E; Hernández, M; Rius, F; Lecube, A

    Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    SLEEP MEDICINE 116 19-26. .

    [doi:10.1016/j.sleep.2024.02.032]

  • Dakterzada, F; Jové, M; Huerto, R; Carnes, A; Sol, J; Pamplona, R; Piñol-Ripoll, G

    Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer's disease

    Geroscience 46 683-696. .

    [doi:10.1007/s11357-023-00989-x]

  • Berdún R; Obis È; Mota-Martorell N; Bassols A; Valent D; Serrano JCE; Martín-Garí M; Rodríguez-Palmero M; Moreno-Muñoz JA; Tibau J; Quintanilla R; Pamplona R; Portero-Otín M; Jové M

    High-Fat Diet-Induced Obesity Increases Brain Mitochondrial Complex I and Lipoxidation-Derived Protein Damage.

    Antioxidants 13 -. .

    [doi:10.3390/antiox13020161]

  • Sol, J; Ortega-Bravo, M; Portero-Otín, M; Pinol-Ripoll, G; Ribas-Ripoll, V; Artigues-Barberà, E; Butí, M; Pamplona, R; Jové, M

    Human lifespan and sex-specific patterns of resilience to disease: a retrospective population-wide cohort study

    BMC MEDICINE 22 17-17. .

    [doi:10.1186/s12916-023-03206-w]

  • Gil-Sánchez A.; Gonzalo H.; Canudes M.; Nogueras L.; González-Mingot C.; Valcheva P.; Torres P.; Serrano J.C.; Peralta S.; Solana M.J.; Brieva L.

    Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

    PHARMACEUTICALS 17 -. .

    [doi:10.3390/ph17040459]

  • Rosell-Daíz, M; Santos-González, E; Motger-Albertí, A; Ramió-Torrentà, L; Garre-Olmo, J; Pérez-Brocal, V; Moya, A; Jové, M; Pamplona, R; Puig, J; Ramos, R; Fernández-Real, JM; Mayneris-Perxachs, J

    Gut microbiota links to serum ferritin and cognition

    Gut Microbes 15 2290318-2290318. .

    [doi:10.1080/19490976.2023.2290318]

  • Sancho--Saldaña, A; Gil-Sánchez, A; González-Mingot, C; Peralta, S; Solana, MJ; Torres, P; Juanes, A; Quibus, L; Ruiz, E; Sanpedro, E; Quirant-Sánchez, B; Martínez-Cáceres, E; Tello, CR; Presas-Rodríguez, S; Rubio, SG; Baron, BP; Ramio-Torrenta, L; Sotoca, J; González-Suarez, I; Eichau, S; Prieto-Gonzalez, JM; Quilez, MRB; Sabin-Muñoz, J; Sánchez-López, AJ; Calatayud, GL; Calles, C; Sempere, AP; Garces, M; Carmona, O; Moral, E; Hervas, JV; Blanco, Y; Sola-Valls, N; Lara, NT; Forero, L; Brieva, L

    Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine 12 -. .

    [doi:10.3390/jcm12237243]